Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Mediterranean Diet Is a Predictor of Progression of Subclinical Atherosclerosis in a Mediterranean Population, The ILERVAS Prospective Cohort Study

  • Rojo López, Marina Idalia|||0000-0001-6748-3156
  • Bermúdez-López, Marcelino|||0000-0002-3188-4158
  • Castro, Eva
  • Farràs-Sallés, Cristina|||0000-0001-5956-4116
  • Torres, Gerard|||0000-0002-1417-7320
  • Pamplona, Reinald|||0000-0003-4337-6107
  • Lecube, Albert|||0000-0001-9684-0183
  • Valdivieso, José Manuel
  • Fernández, Elvira|||0000-0001-5236-1762
  • Julve i Gil, Josep|||0000-0002-6531-2246
  • Castelblanco, Esmeralda|||0000-0002-2061-6270
  • Alonso Pedrol, Núria|||0000-0001-9687-8050
  • Antentas Peraile, María|||0009-0005-8140-203X
  • Barranco-Altirriba, Maria|||0000-0002-1525-210X
  • Perera Lluna, Alexandre|||0000-0001-6427-851X
  • Franch-Nadal, Josep|||0000-0002-5175-1555
  • Granado-Casas, Minerva|||0000-0003-3447-5728
  • Mauricio, Didac|||0000-0002-2868-0250
Atherosclerotic cardiovascular disease remains a major health issue, often developing silently as subclinical atherosclerotic disease (SAD). The Mediterranean diet (MDiet) is known for its cardiovascular benefits, but the combined influence of both MDiet adherence and physical activity (PA) on SAD progression has not been previously documented. Objective: We aimed to investigate how adherence to a healthy lifestyle, defined as MDiet adherence and PA level, influences SAD progression in subjects from the ILERVAS cohort follow-up. Methods: A study on 3097 participants from the ILERVAS prospective cohort was conducted. MDiet adherence was assessed using the MEDAS score, and PA categories were established using the IPAQ, both categorized into low, moderate, and high levels. Two different lifestyle scores integrating the MDiet and PA categories were built. The presence of atherosclerotic plaques was assessed by carotid and femoral ultrasound examination. Demographic, clinical, and biochemical data were also obtained. Multivariable linear, logistic, and Poisson regression models adjusted for potential confounders were used to analyze the association between the lifestyle scores and SAD progression, as well as the MDiet and PA as separate variables and number of territories with plaque. Results: A healthier lifestyle score did not show an effect on SAD progression. However, a higher MEDAS score was associated with a 3% decrease in the number of territories with plaque (IRR 0.97, 95% CI 0.96-0.99, p < 0.001), suggesting a protective effect of the adherence to the MDiet. PA did not show a significant association (IRR 1.00, 95% CI 1.00-1.00, p = 0.269). Older age, hypertension, dyslipidemia, smoking, and lower eGFR were associated with SAD progression, while the female sex was protective (IRR 0.67, 95% CI 0.63-0.72, p < 0.001). Conclusions: The findings of this study show that higher adherence to the MDiet is associated with reduced incidence of SAD, indicating its potential role in cardiovascular prevention strategies. Although a higher lifestyle score or physical activity levels did not show any significant effect, promoting the MDiet, alongside managing traditional cardiovascular risk factors, could be an effective public health intervention to prevent atherosclerosis and reduce the burden of cardiovascular disease.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Impact of the new EASO obesity definition on the detection of atheromatosis in subjects with low-to-moderate cardiovascular risk

  • León-Mengíbar, Josep|||0000-0002-5982-3461
  • Bermúdez-López, Marcelino|||0000-0002-3188-4158
  • Valdivielso, José Manuel|||0000-0003-1343-0184
  • Pamplona, Reinald|||0000-0003-4337-6107
  • Torres, Gerard|||0000-0002-1417-7320
  • Mauricio, Didac|||0000-0002-2868-0250
  • Castro-Boqué, Eva|||0000-0002-1013-0007
  • Fernández, Elvira|||0000-0001-5236-1762
  • Caixàs i Pedragós, Assumpta|||0000-0001-8472-9189
  • Bueno, Marta|||0000-0001-9488-4553
  • Ciudin, Andreea|||0000-0001-5622-0203
  • Hernández García, Marta|||0000-0003-1237-298X
  • Simó Canonge, Rafael|||0000-0003-0475-3096
  • Hernández, Cristina|||0000-0002-3109-1721
  • Lecube, Albert|||0000-0001-9684-0183
Traditional body mass index (BMI) does not adequately reflect adipose tissue distribution and associated cardiovascular (CV) risk. To improve risk stratification, the European Association for the Study of Obesity (EASO) proposes to extend the diagnosis of obesity to include individuals with a BMI of 25-30 kg/m², a waist-to-height ratio (WtHR) ≥0.5, and any obesity-related complication. To examine whether this new definition of obesity can better identify the presence of subclinical atheromatosis disease (SAD) in terms of arterial plaque burden compared to the classical BMI-based definition. A cross-sectional including 8,330 participants from the ILERVAS project (ClinicalTrials.gov Identifier: ), aged 45-70 years with low-to-moderate CV risk and no previous CV disease, was included. Obesity was classified using traditional (BMI ≥ 30 kg/m²) and new definitions. Atherosclerosis was assessed through Doppler ultrasound of carotid and femoral arteries. Logistic regression models adjusted for cardiovascular risk factors were used to evaluate associations between obesity definitions and SAD. The new definition increased obesity prevalence from 37.2% to 71.7%. It also revealed higher detection of atheromatous plaques (72.9% vs. 68.6%, p.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

High-Fat Diet-Induced Obesity Increases Brain Mitochondrial Complex I and Lipoxidation-Derived Protein Damage

  • Berdún, Rebeca
  • Obis, Èlia|||0000-0002-6838-1634
  • Mota-Martorell, Natàlia|||0000-0001-5937-7070
  • Bassols Teixidó, Anna Maria|||0000-0003-4213-2274
  • Valent, Daniel|||0000-0001-6927-3099
  • Serrano, José C. E.
  • Martín-Garí, Meritxell|||0000-0003-0539-7775
  • Rodríguez-Palmero, María
  • Moreno Muñoz, José Antonio
  • Tibau, Joan|||0000-0001-5059-0545
  • Quintanilla, Raquel|||0000-0003-3274-3434
  • Pamplona, Reinald|||0000-0003-4337-6107
  • Portero-Otín, Manuel|||0000-0002-1823-0299
  • Jové, Mariona|||0000-0001-5577-6162
Obesity is a risk factor for highly prevalent age-related neurodegenerative diseases, the pathogenesis of whichinvolves mitochondrial dysfunction and protein oxidative damage. Lipoxidation, driven by high levels of peroxidizable unsaturated fatty acids and low antioxidant protection of the brain, stands out as a significant risk factor. To gain information on the relationship between obesity and brain molecular damage, in a porcine model of obesity we evaluated (1) the level of mitochondrial respiratory chain complexes, as the main source of free radical generation, by Western blot; (2) the fatty acid profile by gas chromatography; and (3) the oxidative modification of proteins by mass spectrometry. The results demonstrate a selectively higher amount of the lipoxidation-derived biomarker malondialdehyde-lysine (MDAL) (34% increase) in the frontal cortex, and positive correlations between MDAL and LDL levels and body weight. No changes were observed in brain fatty acid profile by the high-fat diet, and the increased lipid peroxidative modification was associated with increased levels of mitochondrial complex I (NDUFS3 and NDUFA9 subunits) and complex II (flavoprotein). Interestingly, introducing n3 fatty acids and a probiotic in the high-fat diet prevented the observed changes, suggesting that dietary components can modulate protein oxidative modification at the cerebral level and opening new possibilities in neurodegenerative diseases' prevention.